{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:14:30Z","timestamp":1763968470640,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ajg.2021.12.003","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T10:49:46Z","timestamp":1643798986000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C"],"prefix":"10.1016","volume":"23","author":[{"given":"Sarra","family":"Melayah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouafa","family":"Kallala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Ben Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Fodha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloua","family":"Yacoub Jemni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtissem","family":"Ghedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Manka\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2021.12.003_b0005","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.3389\/fimmu.2021.726820","article-title":"Antiphospholipid Antibody Assays in 2021: Looking for a predictive value in addition to a diagnostic one","volume":"12","author":"Meroni","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajg.2021.12.003_b0010","doi-asserted-by":"crossref","unstructured":"Jiang D, Lim W, Crowther MA, Garcia D. A systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations. Blood Adv 2021:bloodadvances.2021005205.","DOI":"10.1182\/bloodadvances.2021005205"},{"key":"10.1016\/j.ajg.2021.12.003_b0015","doi-asserted-by":"crossref","first-page":"100610","DOI":"10.1016\/j.blre.2019.100610","article-title":"The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.ajg.2021.12.003_b0020","article-title":"The weight of IgA Anti-\u03b22glycoprotein I in the antiphospholipid syndrome cathogenesis: closing the gap of seronegative antiphospholipid syndrome","author":"Cabrera-Marante","year":"2020218972","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ajg.2021.12.003_b0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ajg.2021.12.003_b0030","first-page":"267","article-title":"19 Study Group\/European Forum on Antiphospholipid Antibodies. Beta-2-glycoprotein-I deficiency could precipitate an antiphospholipid syndrome-like prothrombotic situation in patients with Coronavirus disease 2019. ACR Open","volume":"3","author":"Serrano","year":"2021","journal-title":"Rheumatol"},{"issue":"5","key":"10.1016\/j.ajg.2021.12.003_b0035","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.thromres.2013.03.003","article-title":"Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-\u03b22glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients","volume":"131","author":"Hadhri","year":"2013","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.ajg.2021.12.003_b0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/TP.0000000000001199","article-title":"The presence of pretransplant antiphospholipid antibodies IgA anti-\u03b2-2-glycoprotein I as a predictor of graft thrombosis after renal transplantation","volume":"101","author":"Morales","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ajg.2021.12.003_b0045","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.3389\/fimmu.2019.02891","article-title":"Immune complexes of Beta-2-Glycoprotein I and IgA antiphospholipid antibodies identify patients with elevated risk of thrombosis and early mortality after heart transplantation","volume":"10","author":"Serrano","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajg.2021.12.003_b0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajg.2021.07.002","article-title":"Hepatitis C elimination in Africa: Seizing the moment for hepatitis-C free future","volume":"22","author":"Cordie","year":"2021","journal-title":"Arab J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ajg.2021.12.003_b0055","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00705-019-04308-8","article-title":"Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study","volume":"164","author":"Bettaieb","year":"2019","journal-title":"Arch Virol"},{"issue":"4","key":"10.1016\/j.ajg.2021.12.003_b0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0961203317731532","article-title":"Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis","volume":"27","author":"Abdel-Wahab","year":"2018","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.ajg.2021.12.003_b0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1590\/S0100-879X2008005000024","article-title":"Antiphospholipid antibodies in Brazilian hepatitis C virus carriers","volume":"41","author":"Atta","year":"2008","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"10.1016\/j.ajg.2021.12.003_b0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10875-008-9211-6","article-title":"IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases","volume":"28","author":"Gabeta","year":"2008","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.ajg.2021.12.003_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23217","article-title":"IgA is the predominant isotype of anti-\u03b22 glycoprotein I antibodies in rheumatoid arthritis","volume":"34","author":"Melayah","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ajg.2021.12.003_b0080","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2141.1998.00722.x","article-title":"Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C","volume":"101","author":"Leroy","year":"1998","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.ajg.2021.12.003_b0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-2143(98)90096-8","article-title":"Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury","volume":"131","author":"Biron","year":"1998","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.ajg.2021.12.003_b0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"21","key":"10.1016\/j.ajg.2021.12.003_b0095","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Longo","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajg.2021.12.003_b0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2362.2003.01110.x","article-title":"Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome","volume":"33","author":"Zachou","year":"2003","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajg.2021.12.003_b0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CDLI.7.2.241-244.2000","article-title":"Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome","volume":"7","author":"Ordi-Ros","year":"2000","journal-title":"ClinDiagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.ajg.2021.12.003_b0110","first-page":"173","article-title":"Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"140","author":"Alessandri","year":"2005","journal-title":"ClinExpImmunol"},{"key":"10.1016\/j.ajg.2021.12.003_b0115","first-page":"444","article-title":"Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Grouped'Etudes sur l'H\u00e9mostaseet la Thrombose)","volume":"73","author":"Reber","year":"1995","journal-title":"ThrombHaemost"},{"issue":"5","key":"10.1016\/j.ajg.2021.12.003_b0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jcla.21529","article-title":"Clinical relevance of antibodies to cardiolipin in patients with chronic hepatitis C","volume":"26","author":"Himoto","year":"2012","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"10.1016\/j.ajg.2021.12.003_b0125","first-page":"190","article-title":"Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations","volume":"112","author":"Blank","year":"2004","journal-title":"ClinImmunol."},{"issue":"10","key":"10.1016\/j.ajg.2021.12.003_b0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.imbio.2005.10.004","article-title":"The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity","volume":"210","author":"Harel","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.ajg.2021.12.003_b0135","doi-asserted-by":"crossref","unstructured":"Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K, et al. Gut dysbiosis associated with hepatitis C virus Infection. Clin Infect Dis 2018;67:869-77.","DOI":"10.1093\/cid\/ciy205"},{"key":"10.1016\/j.ajg.2021.12.003_b0140","first-page":"1","article-title":"Advances in Gut microbiota of viral Hepatitis cirrhosis","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.ajg.2021.12.003_b0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.ajg.2021.12.003_b0150","first-page":"472","article-title":"The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome","volume":"17","author":"Ruff","year":"2015","journal-title":"CurrRheumatol Rep"},{"issue":"9","key":"10.1016\/j.ajg.2021.12.003_b0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection","volume":"11","author":"Preveden","year":"2017","journal-title":"Expert Rev GastroenterolHepatol"},{"issue":"05","key":"10.1016\/j.ajg.2021.12.003_b0160","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1055\/s-0038-1649940","article-title":"Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome","volume":"74","author":"Pierangeli","year":"1995","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.ajg.2021.12.003_b0165","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/art.38131","article-title":"Value of isolated IgA anti-\u03b22-glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome","volume":"65","author":"Murthy","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajg.2021.12.003_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/704395","article-title":"Isolated IgA anti-\u03b22 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome","volume":"2014","author":"Ruiz-Garc\u00eda","year":"2014","journal-title":"J Immunol Res"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197921000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:45:06Z","timestamp":1761659106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197921000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1687197921000988"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2021.12.003","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}